Question 1

What is spinal muscular atrophy (SMA), and what does it mean?

Accepted Answer

SMA is a genetic neuromuscular disorder characterized by the loss of motor neurons in the spinal cord, leading to progressive muscle weakness and wasting. It commonly appears in infancy or early childhood, though milder forms can present later.
Source: Wikipedia

Question 2

What causes spinal muscular atrophy, and how is it inherited?

Accepted Answer

SMA is primarily caused by mutations in the SMN1 gene, which is essential for motor neuron survival. It follows an autosomal recessive inheritance pattern—requiring two faulty copies for the condition to manifest.
Source: Muscular Dystrophy Association

Question 3

What are the symptoms of spinal muscular atrophy, especially in Type 1?

Accepted Answer

SMA Type 1, the most severe form, appears in infancy. It manifests as hypotonia (“floppy baby” syndrome), poor head control, difficulty breathing, swallowing challenges, and limited movement. Affected infants often cannot sit unassisted.
Source: Children’s Hospital

Question 4

Can spinal muscular atrophy be diagnosed during pregnancy or seen on ultrasound?

Accepted Answer

While ultrasound findings—such as reduced fetal movement—might raise suspicion, genetic testing (via CVS or amniocentesis) offers a definitive prenatal diagnosis.
Source: NIH NINDS

Question 5

Can SMA be seen on an ultrasound or through genetic testing?

Accepted Answer

Ultrasound may show signs like decreased fetal movement in severe cases, but it’s not a reliable diagnostic tool. Genetic testing is the most accurate method for identifying SMA or carrier status.

Question 6

How is spinal muscular atrophy diagnosed after birth?

Accepted Answer

Diagnosis is confirmed through genetic testing of the SMN1 gene. In many U.S. states, newborn screening includes SMA, enabling early detection and intervention.
Source: SMA Newborn Screening Guide

Question 7

How does SMA affect the body and motor function over time?

Accepted Answer

SMA causes progressive muscle weakness, especially in proximal muscles (near the torso), impairing abilities like sitting, walking, breathing, and swallowing. The extent varies by SMA type.
Source: NYP Orthopedics

Question 8

Can spinal muscular atrophy be treated or managed effectively?

Accepted Answer

Yes, treatment options include gene therapy (like Zolgensma), SMN-enhancing drugs (like Spinraza and Evrysdi), and supportive care. While there’s no universal cure, early treatment can significantly improve quality of life and survival.

Question 9

Is there a cure for SMA, and why are some treatments expensive?

Accepted Answer

There’s currently no cure, but early interventions—especially gene therapy—can dramatically slow disease progression. These treatments are costly due to complex development processes and the rarity of SMA.
Source: NCBI (Gene Therapy Review)

Question 10

Who is affected by SMA, and who treats this condition?

Accepted Answer

SMA affects individuals of all ages but is most commonly diagnosed in infancy or early childhood. It is treated by neurologists, geneticists, and multidisciplinary care teams including physical therapists and respiratory specialists.

Spinal Muscular Atrophy Sma Medications